The role of 18F-fluorodeoxyglucose positron emission tomography/computed tomography–derived parameters as prognostic factors in patients undergoing resection for pancreatic ductal adenocarcinoma
{"title":"The role of 18F-fluorodeoxyglucose positron emission tomography/computed tomography–derived parameters as prognostic factors in patients undergoing resection for pancreatic ductal adenocarcinoma","authors":"Francesco Lancellotti MD , Agastya Patel MD , Savvas Tsaramanidis MD , Elbert Edy MBChB , Thomas Satyadas MD , Rafik Filobbos MD , Saurabh Jamdar MD , Sharon Barker NP , Ajith Kumar Siriwardena FRCS , Nicola de Liguori-Carino MD","doi":"10.1016/j.surg.2025.109271","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><div>The aim of this study is to investigate the role of maximum standardized uptake and tumor-to-liver ratio derived from preoperative <sup>18</sup>F-fluorodeoxyglucose positron emission tomography/computed tomography in patients with pancreatic ductal adenocarcinoma.</div></div><div><h3>Methods</h3><div>Patients who underwent pancreatic resection from January 2015 to December 2022 were reviewed. Patients were grouped based on disease-free survival of 1 year, disease-free survival of 6 months, overall survival of 1 year, and resectability.</div></div><div><h3>Results</h3><div>A total of 133 patients were included in the study. The median maximum standardized uptake was significantly greater in patients with shorter survival than in those with longer survival (disease-free survival <1 year vs >1 year: 7.1 [4.3–9.1] vs 4.9 [3.3–6.5], <em>P</em> < .001; disease-free survival <6 months vs >6 months: 8 [4.5–9.7] vs 5.2 [3.4–6.8], <em>P</em> = .001; overall survival <1 year vs >1 year: 6.9 [4.4–8.8] vs 5 [3.4–6.9], <em>P</em> = .01). Median maximum standardized uptake was significantly greater in patients with intraoperative findings of unresectable disease than in those who underwent surgical resection (7.4 [5.5–9.5] vs 5.5 [3.8–7.8], <em>P</em> = .02). These findings were consistent for tumor-to-liver ratio for all groupings. The area under the curve based on receiver operating characteristic analysis was 0.7 for both maximum standardized uptake and tumor-to-liver ratio for predicting disease-free survival, overall survival, and resectability.</div></div><div><h3>Conclusion</h3><div>Preoperative <sup>18</sup>F-fluorodeoxyglucose positron emission tomography/computed tomography maximum standardized uptake and tumor-to-liver ratio are indicators of resectability, early recurrence, and poor prognosis in patients with pancreatic ductal adenocarcinoma. A maximum standardized uptake value between 5 and 7 is a potential red flag, and further investigations should be considered before proceeding to a pancreatic resection.</div></div>","PeriodicalId":22152,"journal":{"name":"Surgery","volume":"181 ","pages":"Article 109271"},"PeriodicalIF":3.2000,"publicationDate":"2025-03-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Surgery","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0039606025001230","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"SURGERY","Score":null,"Total":0}
引用次数: 0
Abstract
Background
The aim of this study is to investigate the role of maximum standardized uptake and tumor-to-liver ratio derived from preoperative 18F-fluorodeoxyglucose positron emission tomography/computed tomography in patients with pancreatic ductal adenocarcinoma.
Methods
Patients who underwent pancreatic resection from January 2015 to December 2022 were reviewed. Patients were grouped based on disease-free survival of 1 year, disease-free survival of 6 months, overall survival of 1 year, and resectability.
Results
A total of 133 patients were included in the study. The median maximum standardized uptake was significantly greater in patients with shorter survival than in those with longer survival (disease-free survival <1 year vs >1 year: 7.1 [4.3–9.1] vs 4.9 [3.3–6.5], P < .001; disease-free survival <6 months vs >6 months: 8 [4.5–9.7] vs 5.2 [3.4–6.8], P = .001; overall survival <1 year vs >1 year: 6.9 [4.4–8.8] vs 5 [3.4–6.9], P = .01). Median maximum standardized uptake was significantly greater in patients with intraoperative findings of unresectable disease than in those who underwent surgical resection (7.4 [5.5–9.5] vs 5.5 [3.8–7.8], P = .02). These findings were consistent for tumor-to-liver ratio for all groupings. The area under the curve based on receiver operating characteristic analysis was 0.7 for both maximum standardized uptake and tumor-to-liver ratio for predicting disease-free survival, overall survival, and resectability.
Conclusion
Preoperative 18F-fluorodeoxyglucose positron emission tomography/computed tomography maximum standardized uptake and tumor-to-liver ratio are indicators of resectability, early recurrence, and poor prognosis in patients with pancreatic ductal adenocarcinoma. A maximum standardized uptake value between 5 and 7 is a potential red flag, and further investigations should be considered before proceeding to a pancreatic resection.
期刊介绍：
For 66 years, Surgery has published practical, authoritative information about procedures, clinical advances, and major trends shaping general surgery. Each issue features original scientific contributions and clinical reports. Peer-reviewed articles cover topics in oncology, trauma, gastrointestinal, vascular, and transplantation surgery. The journal also publishes papers from the meetings of its sponsoring societies, the Society of University Surgeons, the Central Surgical Association, and the American Association of Endocrine Surgeons.
京公网安备 11010802042870号
京ICP备2023020795号-1
分享
求助内容：
应助结果提醒方式：
扫码关注我们
